NO913524D0 - Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav. - Google Patents
Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav.Info
- Publication number
- NO913524D0 NO913524D0 NO913524A NO913524A NO913524D0 NO 913524 D0 NO913524 D0 NO 913524D0 NO 913524 A NO913524 A NO 913524A NO 913524 A NO913524 A NO 913524A NO 913524 D0 NO913524 D0 NO 913524D0
- Authority
- NO
- Norway
- Prior art keywords
- franeisseria
- meningitidis
- membrane protein
- outer membrane
- sequence coding
- Prior art date
Links
- 101710116435 Outer membrane protein Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
- C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
- C12Y108/01004—Dihydrolipoyl dehydrogenase (1.8.1.4), i.e. lipoamide-dehydrogenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0051—Oxidoreductases (1.) acting on a sulfur group of donors (1.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU90145A CU22302A1 (es) | 1990-09-07 | 1990-09-07 | Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales |
Publications (1)
Publication Number | Publication Date |
---|---|
NO913524D0 true NO913524D0 (no) | 1991-09-06 |
Family
ID=5459451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO913524A NO913524D0 (no) | 1990-09-07 | 1991-09-06 | Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5286484A (no) |
EP (1) | EP0474313B1 (no) |
JP (1) | JP3253327B2 (no) |
AR (1) | AR245778A1 (no) |
AT (1) | ATE152175T1 (no) |
AU (1) | AU657487B2 (no) |
CA (1) | CA2050749C (no) |
CU (1) | CU22302A1 (no) |
DE (1) | DE69125769T2 (no) |
ES (1) | ES2103295T3 (no) |
FI (1) | FI103511B1 (no) |
GR (1) | GR3024127T3 (no) |
IL (1) | IL99401A (no) |
NO (1) | NO913524D0 (no) |
RU (1) | RU2132383C1 (no) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7118757B1 (en) * | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
AT402367B (de) * | 1990-10-11 | 1997-04-25 | Immuno Ag | Pharmazeutische zubereitung auf basis von lys-plasminogen |
US5439808A (en) * | 1993-07-23 | 1995-08-08 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
WO1996000233A1 (en) * | 1994-06-24 | 1996-01-04 | Children's Hospital And Medical Center | Escherichia coli o157:h7 epithelial adhesin |
US5545553A (en) * | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
US6287574B1 (en) | 1995-03-17 | 2001-09-11 | Biochem Pharma Inc. | Proteinase K resistant surface protein of neisseria meningitidis |
US5747287A (en) * | 1995-04-28 | 1998-05-05 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
CU22559A1 (es) * | 1996-01-17 | 1999-05-03 | Ct Ingenieria Genetica Biotech | Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión |
EP0970966B1 (en) * | 1996-09-04 | 2008-02-20 | Takara Bio Inc. | Fungal antigens and process for producing the same |
EP2278011A3 (en) * | 1998-01-14 | 2012-03-07 | Novartis Vaccines and Diagnostics S.r.l. | Neisseria meningitidis antigens |
AU3968599A (en) * | 1998-04-29 | 1999-11-16 | American Cyanamid Company | Vaccines containing recombinant pilin against Neisseria Gonorrhoeae or Neisseria Meningitidis |
AU761780B2 (en) * | 1998-05-01 | 2003-06-12 | Glaxosmithkline Biologicals Sa | Neisseria meningitidis antigens and compositions |
US6693186B2 (en) * | 1998-09-01 | 2004-02-17 | Antex Biologics Inc | Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
US6756493B1 (en) * | 1998-09-01 | 2004-06-29 | Antex Biologics, Inc. | Nucleic acid sequence and uses thereof |
MXPA01003557A (es) * | 1998-10-09 | 2004-04-05 | Chiron Corp | Secuencias genomicas de neisseria y metodos para su uso. |
EP1535928B1 (en) * | 1998-10-22 | 2008-07-16 | The University of Montana | Vaccine compositions comprising Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis |
US6610306B2 (en) | 1998-10-22 | 2003-08-26 | The University Of Montana | OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof |
CA2347849C (en) * | 1998-10-22 | 2013-06-25 | The University Of Montana | Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
DE69839740D1 (de) | 1998-10-22 | 2008-08-28 | Univ Montana | Vakzine enthaltend Omp85 Proteine von Neisseria gonorrhoeae und Neisseria meningitidis |
JP4763210B2 (ja) | 2000-02-28 | 2011-08-31 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | ナイセリアのタンパク質の異種発現 |
WO2001081422A1 (en) * | 2000-04-20 | 2001-11-01 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Secretory tyrosine phosphatases from mycobacteria |
CU23077A1 (es) * | 2000-12-06 | 2005-08-17 | Centro Inmunologia Molecular | Composicion vacunal que contiene factor de crecimiento transformante (tgf-alfa). su uso en la terapia de enfermedades malignas |
CU23245A1 (es) * | 2001-07-16 | 2007-10-17 | Inst De Medicina Tropical Pedr | CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS |
GB0121591D0 (en) * | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
US7795210B2 (en) | 2001-10-10 | 2010-09-14 | Novo Nordisk A/S | Protein remodeling methods and proteins/peptides produced by the methods |
US7696163B2 (en) | 2001-10-10 | 2010-04-13 | Novo Nordisk A/S | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US7173003B2 (en) | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US8008252B2 (en) | 2001-10-10 | 2011-08-30 | Novo Nordisk A/S | Factor VII: remodeling and glycoconjugation of Factor VII |
MXPA04012496A (es) | 2002-06-21 | 2005-09-12 | Novo Nordisk Healthcare Ag | Glicoformos del factor vii pegilados. |
EP2255826B1 (en) * | 2002-08-02 | 2016-04-13 | GlaxoSmithKline Biologicals S.A. | Neisserial vaccine compositions comprising a combination of antigens |
PT2353608T (pt) * | 2002-10-11 | 2020-03-11 | Novartis Vaccines And Diagnostics S R L | Vacinas de polipéptidos para protecção alargada contra linhagens meningocócicas hipervirulentas |
CN1738642A (zh) * | 2002-11-14 | 2006-02-22 | 血清疫苗研究生产中心芬雷学院 | 获得缀合疫苗的方法和含有该缀合疫苗的疫苗组合物 |
CA2519092C (en) | 2003-03-14 | 2014-08-05 | Neose Technologies, Inc. | Branched water-soluble polymers and their conjugates |
WO2004091499A2 (en) | 2003-04-09 | 2004-10-28 | Neose Technologies, Inc. | Intracellular formation of peptide conjugates |
EP1615945B1 (en) | 2003-04-09 | 2011-09-28 | BioGeneriX AG | Glycopegylation methods and proteins/peptides produced by the methods |
ATE540055T1 (de) | 2003-05-09 | 2012-01-15 | Biogenerix Ag | Zusammensetzungen und verfahren zur herstellung von glykosylierungsmutanten des menschlichen wachstumshormons |
US9005625B2 (en) | 2003-07-25 | 2015-04-14 | Novo Nordisk A/S | Antibody toxin conjugates |
US8633157B2 (en) | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
US7956032B2 (en) | 2003-12-03 | 2011-06-07 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
CN101072789B (zh) | 2004-01-08 | 2013-05-15 | 生物种属学股份公司 | 肽的o-连接的糖基化 |
US20080300173A1 (en) | 2004-07-13 | 2008-12-04 | Defrees Shawn | Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1] |
WO2006031811A2 (en) | 2004-09-10 | 2006-03-23 | Neose Technologies, Inc. | Glycopegylated interferon alpha |
HUE026826T2 (en) | 2004-10-29 | 2016-07-28 | Ratiopharm Gmbh | Modeling and glycopegylation of fibroblast growth factor (FGF) |
CU23297A1 (es) * | 2004-11-16 | 2008-07-24 | Ct De Inmunologa A Molecular | Formulaciones inmunoterapã0/00uticas para la inducciã"n de autoanticuerpos bloqueadores de la uniã"n de interleucina-2 a su receptor. su uso en el tratamiento del cã ncer |
ES2449195T3 (es) | 2005-01-10 | 2014-03-18 | Ratiopharm Gmbh | Factor estimulante de colonias de granulocitos glicopegilado |
WO2006121569A2 (en) | 2005-04-08 | 2006-11-16 | Neose Technologies, Inc. | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
EP1888098A2 (en) | 2005-05-25 | 2008-02-20 | Neose Technologies, Inc. | Glycopegylated erythropoietin formulations |
US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
CU23578A1 (es) | 2005-09-16 | 2010-09-30 | Ct Ingenieria Genetica Biotech | Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal |
US20090048440A1 (en) | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes |
ES2516694T3 (es) | 2006-07-21 | 2014-10-31 | Ratiopharm Gmbh | Glicosilación de péptidos a través de secuencias de glicosilación con unión en O |
US8969532B2 (en) | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
CU23630A1 (es) | 2006-10-30 | 2011-02-24 | Ct Ingenieria Genetica Biotech | Moléculas peptídicas quiméricas con propiedades antivirales contra los virus de la familia flaviviridae |
PL2144923T3 (pl) | 2007-04-03 | 2013-12-31 | Biogenerix Ag | Sposoby leczenia z użyciem glikopegilowanego G-CSF |
US9493499B2 (en) | 2007-06-12 | 2016-11-15 | Novo Nordisk A/S | Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography |
US8207112B2 (en) | 2007-08-29 | 2012-06-26 | Biogenerix Ag | Liquid formulation of G-CSF conjugate |
WO2009108806A1 (en) | 2008-02-27 | 2009-09-03 | Novo Nordisk A/S | Conjugated factor viii molecules |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4459286A (en) * | 1983-01-31 | 1984-07-10 | Merck & Co., Inc. | Coupled H. influenzae type B vaccine |
JPH01125328A (ja) * | 1987-07-30 | 1989-05-17 | Centro Natl De Biopreparados | 髄膜炎菌ワクチン |
-
1990
- 1990-09-07 CU CU90145A patent/CU22302A1/es unknown
-
1991
- 1991-09-03 FI FI914129A patent/FI103511B1/fi active
- 1991-09-04 IL IL9940191A patent/IL99401A/xx not_active IP Right Cessation
- 1991-09-05 US US07/754,918 patent/US5286484A/en not_active Expired - Lifetime
- 1991-09-05 CA CA002050749A patent/CA2050749C/en not_active Expired - Fee Related
- 1991-09-05 AU AU83683/91A patent/AU657487B2/en not_active Ceased
- 1991-09-06 RU SU5001752A patent/RU2132383C1/ru not_active IP Right Cessation
- 1991-09-06 AR AR91320611A patent/AR245778A1/es active
- 1991-09-06 DE DE69125769T patent/DE69125769T2/de not_active Expired - Fee Related
- 1991-09-06 ES ES91202291T patent/ES2103295T3/es not_active Expired - Lifetime
- 1991-09-06 NO NO913524A patent/NO913524D0/no unknown
- 1991-09-06 EP EP91202291A patent/EP0474313B1/en not_active Expired - Lifetime
- 1991-09-06 AT AT91202291T patent/ATE152175T1/de active
- 1991-09-07 JP JP25587291A patent/JP3253327B2/ja not_active Expired - Fee Related
-
1997
- 1997-07-16 GR GR970401777T patent/GR3024127T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
IL99401A0 (en) | 1992-08-18 |
JP3253327B2 (ja) | 2002-02-04 |
EP0474313B1 (en) | 1997-04-23 |
ES2103295T3 (es) | 1997-09-16 |
GR3024127T3 (en) | 1997-10-31 |
CA2050749A1 (en) | 1992-03-08 |
AU8368391A (en) | 1992-03-12 |
EP0474313A3 (en) | 1993-02-24 |
DE69125769T2 (de) | 1997-11-27 |
EP0474313A2 (en) | 1992-03-11 |
ATE152175T1 (de) | 1997-05-15 |
IL99401A (en) | 2003-12-10 |
RU2132383C1 (ru) | 1999-06-27 |
FI103511B (fi) | 1999-07-15 |
FI914129A (fi) | 1992-03-08 |
CU22302A1 (es) | 1995-01-31 |
DE69125769D1 (de) | 1997-05-28 |
CA2050749C (en) | 2002-07-02 |
FI103511B1 (fi) | 1999-07-15 |
US5286484A (en) | 1994-02-15 |
FI914129A0 (fi) | 1991-09-03 |
JPH06169779A (ja) | 1994-06-21 |
AR245778A1 (es) | 1994-02-28 |
AU657487B2 (en) | 1995-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO913524D0 (no) | Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav. | |
FI913215A0 (fi) | Additionspolymeriseringskatalysator, som aktiveras medelst oxidering. | |
FI896138A0 (fi) | Polyolpolyestrar som fuktighetsbarriaer foer livsmedel. | |
ITTO930280A0 (it) | Menbrana per ultrafiltrazione, diafiltrazione e relativi procedimenti di impiego, verifica e fabbricazione. | |
FI893557A0 (fi) | Polyestrar, som innehaoller en eterbrygga. | |
FI903028A0 (fi) | Polymerbaserade blandningskompositioner, som innehaoller destrukturerad staerkelse. | |
NO166420C (no) | Ventil. | |
FI894600A0 (fi) | Ny sammansaettning som innehaoller isocyanat-reaktiva vaete innehaollande foereningar. | |
DE68905101D1 (de) | Ventil. | |
FI894650A (fi) | Antigen, som associerar till en human tumoer. | |
FI881910A (fi) | Underlag i synnerhet foer personer som saknar roerelsefoermaoga. | |
FI905020A0 (fi) | Orala kompositioner, som innehaoller monoperoxisyror. | |
FI920080A0 (fi) | Kulfaongare, som uppstannar kulor. | |
FI895431A0 (fi) | Material, foerdelaktigt i bandform foer anvaendning som omslagsmaterial. | |
FI890033A (fi) | Bildskaermanordning som innehaoller en vaogformsgenerator. | |
FI890147A0 (fi) | Aemnen som motverkar rytmstoerningar. | |
FI914981A0 (fi) | Triazolopyridazinderivat, foerfarande foer deras framstaellning samt anvaendning som herbicider. | |
FI911218A (fi) | Monteringsplatta, saerskilt foer hus som anvaends i fjaerrkommunikations- och databehandlingsteknik. | |
DK0522059T3 (da) | Fastholdelsesindretning og forbindelsesindretning, som indbefatter fastholdelsesindretningen | |
NO920500D0 (no) | Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav | |
NO901758L (no) | Reninhemmende dipeptider, fremgangsmaate for deres fremstilling, midler som inneholder disse og deres anvendelse. | |
IT1268116B1 (it) | Sedia. | |
FI884358A (fi) | Handverktyg som utfoer fram- och tillbakagaoende roerelse, speciellt en metallsaog. | |
NO904352D0 (no) | Membran-skille anordning, samt fremgangsmaate for fremstilling. | |
FI912694A0 (fi) | Mede foer barnvagn d.v.s. hjaelpanordning som underlaettar hanteringen. |